Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Cancer Surveys
|
January 1, 1995
Screening strategies: a clinical perspective
E P DeAntoni
Cancer
|
November 14, 1997
Eight years of "Prostate Cancer Awareness Week": lessons in screening and early detection. Prostate Cancer Education Council
E P DeAntoni
Oncology (Williston Park, N.Y.)
|
April 1, 1997
Age-specific reference ranges for PSA in the detection of prostate cancer
E P DeAntoni
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1995
Current status of combined androgen blockade: optimal therapy for advanced prostate cancer
E D Crawford, E P DeAntoni
Cancer
|
October 1, 1994
Pretreatment of metastatic disease. Prostate cancer in the older male
E P DeAntoni, E D Crawford
The Urologic Clinics of North America
|
November 1, 1993
PSA as a screening test for prostate cancer
E D Crawford, E P DeAntoni
Journal of Cellular Biochemistry. Supplement
|
January 1, 1996
The role of prostate-specific antigen in the chemoprevention of prostate cancer
E D Crawford, E P DeAntoni, C A Ross
European Urology
|
January 1, 1997
Combined androgen blockade: the gold standard for metastatic prostate cancer
D G McLeod, E D Crawford, E P DeAntoni
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
A cross-sectional study of vasectomy, time since vasectomy and prostate cancer
E P DeAntoni, S Göktaş, J Stenner, et al.
Oncology (Williston Park, N.Y.)
|
August 1, 1997
Prostate cancer clinical trials of the Southwest Oncology Group
E D Crawford, E P DeAntoni, M Hussain, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Cancer Surveys
|
January 1, 1995
Screening strategies: a clinical perspective
E P DeAntoni
Cancer
|
November 14, 1997
Eight years of "Prostate Cancer Awareness Week": lessons in screening and early detection. Prostate Cancer Education Council
E P DeAntoni
Oncology (Williston Park, N.Y.)
|
April 1, 1997
Age-specific reference ranges for PSA in the detection of prostate cancer
E P DeAntoni
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1995
Current status of combined androgen blockade: optimal therapy for advanced prostate cancer
E D Crawford, E P DeAntoni
Cancer
|
October 1, 1994
Pretreatment of metastatic disease. Prostate cancer in the older male
E P DeAntoni, E D Crawford
The Urologic Clinics of North America
|
November 1, 1993
PSA as a screening test for prostate cancer
E D Crawford, E P DeAntoni
Journal of Cellular Biochemistry. Supplement
|
January 1, 1996
The role of prostate-specific antigen in the chemoprevention of prostate cancer
E D Crawford, E P DeAntoni, C A Ross
European Urology
|
January 1, 1997
Combined androgen blockade: the gold standard for metastatic prostate cancer
D G McLeod, E D Crawford, E P DeAntoni
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
A cross-sectional study of vasectomy, time since vasectomy and prostate cancer
E P DeAntoni, S Göktaş, J Stenner, et al.
Oncology (Williston Park, N.Y.)
|
August 1, 1997
Prostate cancer clinical trials of the Southwest Oncology Group
E D Crawford, E P DeAntoni, M Hussain, et al.
Page
of 2